Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Penumbra System ACE 64 and ACE 68 Reperfusion Catheters

K-Number: K152541 · 2016-01-13

ApplicantPenumbra, Inc.
Decision Date2016-01-13
Product CodeNRY
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Penumbra System ACE 64 and ACE 68 Reperfusion Catheters is a medical device manufactured by Penumbra, Inc.. It received FDA 510(k) clearance on 2016-01-13 under approval number K152541. The device is classified under product code NRY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Penumbra System ACE 64 and ACE 68 Reperfusion Catheters?

Penumbra System ACE 64 and ACE 68 Reperfusion Catheters is a medical device that received FDA 510(k) clearance on 2016-01-13. It is manufactured by Penumbra, Inc.. The 510(k) number is K152541.

When was Penumbra System ACE 64 and ACE 68 Reperfusion Catheters approved by the FDA?

Penumbra System ACE 64 and ACE 68 Reperfusion Catheters received FDA 510(k) clearance on 2016-01-13, under approval number K152541.

What company makes Penumbra System ACE 64 and ACE 68 Reperfusion Catheters?

Penumbra System ACE 64 and ACE 68 Reperfusion Catheters is manufactured by Penumbra, Inc..

What is the FDA product code for Penumbra System ACE 64 and ACE 68 Reperfusion Catheters?

The FDA product code for Penumbra System ACE 64 and ACE 68 Reperfusion Catheters is NRY.

Related Clinical Trials

NCT06170606 POLARx Post Approval Study (POLARx PAS) ACTIVE_NOT_RECRUITING NCT06735534 Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System RECRUITING NCT01630707 Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack COMPLETED NCT06249776 Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial COMPLETED NCT06795763 Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures ENROLLING_BY_INVITATION NCT07214220 Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation RECRUITING

Other Devices by Penumbra, Inc.

K161506Penumbra Aspiration System K161640Penumbra System ACE 68 Reperfusion Catheter K161523INDIGO Aspiration System K161064Penumbra System ACE 68 Reperfusion Catheter K160449Penumbra System, Penumbra Pump MAX K160533Penumbra Embolectomy Aspiration System (INDIGOTM Aspiration System)

View all 59 devices →

Related Devices (Code: NRY)

K161879Solitaire Platinum Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular K161640Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K161064Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. K160449Penumbra System, Penumbra Pump MAXPenumbra, Inc. K172448Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular K162901Penumbra 3D Revascularization DevicePenumbra, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑